Header Fire1

We are very pleased to be involved in FIRE1, a company with an experienced team that is developing a new monitoring device for heart failure. The current financing will be used to complete a first-in-human study as well as for the submission of an IDE.

Patrick Van Beneden - Partner in Gimv's Health & Care team


The Foundry Innovation and Research 1, Ltd. (FIRE1), was founded in 2013 and is the first European spinout of The Foundry, a highly successful medical device incubator from Menlo Park, California. The company, located in Ireland, focuses on developing a novel remote monitoring device to improve outcomes for patients suffering from an increased risk of heart failure. Early detection enables a timely intervention and adjustment of pharmacotherapy, thus avoiding hospitalisation, improving quality of life and lowering health care costs.

Icon entry


Icon location


When ambition meets ambition

FIRE1 is active in a market with growing unmet needs, as cardiac disease is currently the world’s leading cause of death. 

Together, we build a leading company

The financing provides FIRE1 with capital to further advance its novel remote monitoring solution to improve outcomes for heart failure patients.


Monitoring device used in case of risk of heart failure